Division of Acute Care and Trauma Surgery, Department of General Surgery, University of North Carolina Chapel Hill School of Medicine, Chapel Hill, NC, USA.
Am Surg. 2023 Jun;89(6):2755-2757. doi: 10.1177/00031348211047489. Epub 2021 Oct 13.
Severe asthma affects approximately 1-2% of all asthmatic patients. Acute exacerbations are associated with high mortality in this population. There are many treatment options for asthma exacerbation; however, if these treatments fail, patients can develop progressive hypoxia, hypercarbia, respiratory acidosis, and hemodynamic instability. Extracorporeal membrane oxygenation (ECMO) and inhaled anesthetic both have a role in the management of acute severe refractory asthma exacerbation, though there is limited information about the use of both together. We present the case of a patient with severe asthma who suffered a refractory asthma exacerbation and was successfully managed with veno-venous ECMO and inhaled anesthetic. ECMO and inhaled volatile anesthetic both have a role in the management of severe refractory asthma exacerbations. It is safe and beneficial to use these therapies together and more benefit is noted if initiated early in the course of the patient's illness.
严重哮喘影响约 1-2%的所有哮喘患者。在这一人群中,急性加重与高死亡率相关。哮喘发作有许多治疗选择;然而,如果这些治疗失败,患者可能会发展为进行性低氧血症、高碳酸血症、呼吸性酸中毒和血流动力学不稳定。体外膜氧合 (ECMO) 和吸入麻醉剂在急性严重难治性哮喘发作的管理中都有作用,尽管关于两者同时使用的信息有限。我们报告了一例严重哮喘患者的病例,该患者患有难治性哮喘发作,通过静脉-静脉 ECMO 和吸入麻醉剂成功治疗。ECMO 和吸入挥发性麻醉剂在严重难治性哮喘发作的管理中都有作用。同时使用这些治疗方法是安全且有益的,如果在患者疾病早期开始使用,益处更大。